Tumour suppressor and uses thereof

Details for Australian Patent Application No. 2001263952 (hide)

Owner Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research

Inventors Maira, Sauveur-Michel; Hemmings, Brian Arthur

Agent Davies Collison Cave

Pub. Number AU-B-2001263952

PCT Pub. Number WO01/94581

Priority 0014185 09.06.00 GB

Filing date 7 June 2001

Wipo publication date 17 December 2001

Acceptance publication date 21 July 2005

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

A61K 038/17 Medicinal preparations containing peptides - from animals

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 014/47 Peptides having more than 20 amino acids

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

21 July 2005 Application Accepted

  Published as AU-B-2001263952

17 November 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001263953

2001263951